Sale!

COG7 Gene Glycosylation Disorder Type 2E Genetic Test

4,400 د.إ

-21%

The COG7 Gene Glycosylation Disorder Type 2E Genetic Test is a specialized diagnostic examination conducted to identify mutations in the COG7 gene, which can lead to Congenital Disorders of Glycosylation Type IIe (CDG-IIe). These disorders are a group of inherited conditions that affect the normal process of glycosylation – the addition of sugar chains to proteins and lipids, which is crucial for their proper function. Symptoms of CDG-IIe can vary but often include developmental delay, neurological issues, and abnormalities in liver function.

The test is specifically designed to detect genetic anomalies within the COG7 gene by analyzing the patient’s DNA, helping in the accurate diagnosis of the disorder. This is crucial for the management and treatment of the condition, allowing healthcare providers to tailor interventions according to the individual’s genetic makeup.

The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the COG7 Gene Glycosylation Disorder Type 2E Genetic Test is 4400 AED. This investment in health enables patients and their families to gain valuable insights into their genetic conditions, facilitating informed decisions regarding healthcare and potential treatments.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COG7 Gene Glycosylation Disorder Type 2E Genetic Test

At DNA Labs UAE, we offer the COG7 Gene Glycosylation Disorder Type 2E Genetic Test to diagnose and guide treatment for this rare genetic disorder. This test analyzes the COG7 gene for mutations using next-generation sequencing (NGS) technology.

Test Components and Price

The COG7 Gene Glycosylation Disorder Type 2E Genetic Test is priced at 4400.0 AED. The test can be performed on blood or extracted DNA samples. Alternatively, one drop of blood can be collected on an FTA card.

Report Delivery and Test Method

The test results are typically delivered within 3 to 4 weeks. The NGS technology is used to analyze the COG7 gene for mutations.

Test Type and Referring Doctor

The COG7 Gene Glycosylation Disorder Type 2E Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.

Test Department and Pre Test Information

The test is conducted in the Genetics department. Before undergoing the COG7 Gene Glycosylation Disorder Type 2E NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is advised to draw a pedigree chart of family members affected with this disorder.

Test Details and Symptoms

The COG7 gene is responsible for producing a protein involved in the process of glycosylation. Mutations in this gene can result in COG7 Glycosylation Disorder Type 2E, which affects the body’s ability to properly glycosylate proteins and lipids. Symptoms of this disorder include developmental delays, intellectual disability, seizures, and abnormal facial features.

Conclusion

The COG7 Gene Glycosylation Disorder Type 2E Genetic Test offered by DNA Labs UAE is a crucial diagnostic tool for identifying and managing this rare genetic disorder. By analyzing the COG7 gene for mutations, this test can provide valuable insights for treatment and management strategies.

Test Name COG7 Gene Glycosylation disorder type 2E Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COG7 Gene Glycosylation disorder type 2E NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with COG7 Gene Glycosylation disorder type 2E
Test Details

COG7 gene glycosylation disorder type 2E NGS genetic test is a diagnostic test that uses next-generation sequencing (NGS) technology to analyze the COG7 gene for mutations. COG7 gene is responsible for producing a protein that is involved in the process of glycosylation, which is the addition of sugar molecules to proteins and lipids. Mutations in this gene can lead to a rare genetic disorder known as COG7 glycosylation disorder type 2E, which affects the body’s ability to properly glycosylate proteins and lipids. This can result in a wide range of symptoms, including developmental delays, intellectual disability, seizures, and abnormal facial features. The NGS genetic test for COG7 gene mutations can help diagnose this disorder and guide treatment and management strategies.